Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron
Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron
复制标题
DOI:
10.1186/s42826-020-00065-x
复制
发表时间:
2020-09-15
影响因子:
2.9
通讯作者:
Lee, Daekee
中科院分区:
文献类型:
--
作者:
Chin, Hyun Jung;Lee, So-young;Lee, Daekee
Genetically engineered mouse models through gene deletion are useful tools for analyzing gene function. To delete a gene in a certain tissue temporally, tissue-specific and tamoxifen-inducible Cre transgenic mice are generally used. Here, we generated transgenic mouse with cardiac-specific expression of Cre recombinase fused to a mutant estrogen ligand-binding domain (ERT2) on both N-terminal and C-terminal under the regulatory region of human vasoactive intestinal peptide receptor 2 (VIPR2) intron and Hsp68 promoter (VIPR2-ERT2CreERT2). In VIPR2-ERT2CreERT2 transgenic mice, mRNA for Cre gene was highly expressed in the heart. To further reveal heart-specific Cre expression, VIPR2-ERT2CreERT2 mice mated with ROSA26-lacZ reporter mice were examined by X-gal staining. Results of X-gal staining revealed that Cre-dependent recombination occurred only in the heart after treatment with tamoxifen. Taken together, these results demonstrate that VIPR2-ERT2CreERT2 transgenic mouse is a useful model to unveil a specific gene function in the heart.